A detailed history of Gamma Investing LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 334 shares of HROW stock, worth $11,633. This represents 0.0% of its overall portfolio holdings.

Number of Shares
334
Previous 236 41.53%
Holding current value
$11,633
Previous $6.28 Million 62.47%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 14, 2025

BUY
$22.2 - $31.61 $2,175 - $3,097
98 Added 41.53%
334 $10.2 Million
Q1 2025

Apr 14, 2025

SELL
$22.22 - $36.67 $134,253 - $221,560
-6,042 Reduced 96.24%
236 $6.28 Million
Q1 2025

Apr 07, 2025

BUY
$22.22 - $36.67 $133,919 - $221,010
6,027 Added 2401.2%
6,278 $236,000
Q4 2024

Jan 02, 2025

SELL
$33.39 - $57.5 $901 - $1,552
-27 Reduced 9.71%
251 $8.42 Million
Q3 2024

Oct 04, 2024

BUY
$20.85 - $46.47 $4,607 - $10,269
221 Added 387.72%
278 $12.5 Million
Q2 2024

Jul 02, 2024

BUY
$10.0 - $21.64 $570 - $1,233
57 New
57 $1.19 Million

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $943M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.